CD14 and cancer: Interestingly, analysis of human peripheral blood from cancer patients and healthy volunteers revealed a population of VEGFR2+/CD45bright/CD14+ monocytes; this population was significantly more prominent in blood from cancer patients compared to that of healthy volunteers, confirming our pre-clinical findings [68]